At a glance
- Originator Pfizer
- Class Antibacterials
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 11 Sep 2005 Vicuron Pharmaceuticals has been acquired and merged into Pfizer
- 31 Mar 2003 Versicor is now called Vicuron Pharmaceuticals
- 17 Mar 2003 Versicor has merged with Biosearch Italia